Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Adalimumab & Infliximab Remain in Newborns after Delivery

Michele B. Kaufman, PharmD, BCGP  |  June 15, 2016

A recent study showed that, when administered during pregnancy, infliximab takes longer to clear an infant’s system than adalimumab…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabAnti-TNFinflammatory bowel diseaseinfliximabpregnancy

How to Deliver Difficult News about Patients' Diagnoses

How to Deliver Difficult News about Patients’ Diagnoses

Karen Appold  |  July 14, 2015

Telling a patient that he or she has been diagnosed with rheumatoid arthritis (RA), ankylosing spondylitis, fibromyalgia or another debilitating, painful and/or chronic condition can be upsetting for a patient to hear and difficult for a rheumatologist to convey. Given this, it’s important to prepare for the appointment. “Take a few minutes beforehand to contemplate…

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:chronic conditionDiagnosispatient carephysicianrheumatologist

Prior Authorization Requests Delay or Prevent Delivery of Needed Meds

Richard Quinn  |  March 27, 2015

Rheumatologist denounces common practice as a time-draining impediment to patient care

Filed under:Practice Support Tagged with:Health InsuranceMedicationpatient carePractice Managementprior authorizationrheumatologist

Nanoparticle Medicine Delivery Shows Promise

Kurt Ullman  |  June 13, 2013

Researchers treated mouse model of systemic lupus erythematous with mycophenolic acid delivered via nanoparticle. (posted June 18, 2013)

Filed under:Drug Updates Tagged with:LupusNanoparticleSLE

Electronic Prescribing: The First Step Towards an Integrated Health Delivery System?

Staff  |  February 1, 2009

With the introduction of the 2009 Centers for Medicare and Medicaid Services’ (CMS’s) electronic prescribing incentive program, the door is opening for widespread adoption of health information technology (HIT) within the physician’s practice.

Filed under:From the CollegePractice Support Tagged with:Practice Tips

A New Treatment for Fibromyalgia?

Michele B. Kaufman, PharmD, BCGP  |  September 11, 2025

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

Filed under:ConditionsDrug UpdatesPain Syndromes Tagged with:Chronic paincyclobenzaprine HCl tabletFDA approvalFibromyalgiaTonmyaU.S. Food and Drug Administration (FDA)

How ACR Volunteers Educate School Nurses About Childhood-Onset Lupus

From the College  |  September 6, 2025

The ACR’s SHOP initiative partners pediatric rheumatologists & school nurses to raise cSLE awareness & better support students living with lupus.

Filed under:From the College Tagged with:childhood-onset SLEChildrenCollaborative Initiatives Committee (COIN)Pediatric RheumatologySchool NursesSLE Resource CenterThe Lupus Initiative

President’s Corner: ACR/ARP Education That Fits

Carol A. Langford, MD, MHS  |  September 6, 2025

Fulfill your lifelong learning goals with the ACR & ARP. Explore diverse educational options, including journals, podcasts & ACR Convergence 2025.

Filed under:President's Perspective Tagged with:ACR Convergence 2025ACR State-of-the-Art Clinical SymposiumACR Winter Rheumatology SymposiumAssociation of Rheumatology Professionals (ARP)continuing medical educationEducationPediatric Rheumatology SymposiumPresident's Corner

AMA State Advocacy Roundtable Addresses Pressing Policy Challenges

From the College  |  September 5, 2025

The roundtable included discussions on emerging issues in state advocacy, prior authorization reform, likely impacts of the Big Beautiful Bill and physician wellness.

Filed under:Legislation & Advocacy Tagged with:AMAstate legislation

ACR President Warns: Access to Care Is at Risk Without Medicare Payment Reform

From the College  |  September 4, 2025

In a recent commentary published by Medscape, ACR President Carol Langford, MD, MHS, issues a stark warning: If Congress does not reform the physician payment system, patients may face increasing difficulty accessing essential medical services.

Filed under:Legislation & AdvocacyPractice Support Tagged with:Medicare Physician Fee Schedule (MPFS)physician payment reform

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences